|
|
|
|
D5290
|
(−)-3,4-Dihydroxynorephedrine ≥90%
|
|
E4250
|
(−)-Epinephrine
|
|
02252
|
(−)-Epinephrine USP
|
|
A7257
|
(−)-Norepinephrine ≥98%, crystalline
|
|
E1635
|
(±)-Epinephrine ≥98%
|
|
62320
|
(±)-α-Lipoic acid BioChemika, ≥98.0% (HPLC)
|
|
T1395
|
(±)-α-Lipoic acid cell culture tested, ≥99%
|
|
T5625
|
(±)-α-Lipoic acid synthetic, ≥99% (titration), powder
|
|
282553
|
(1R,2S)-(−)-Norephedrine 99%
|
|
S7771
|
(S)-(−)-Sulpiride ≥98% (HPLC)
|
|
34002
|
(S)-(−)-Sulpiride VETRANAL®, analytical standard
|
|
M22601
|
1-(2-Methoxyphenyl)piperazine 98%
|
|
65225
|
1-(2-Methoxyphenyl)piperazine purum, ≥97.0% (NT)
|
|
547905
|
2,2′:5′,2′′:5′′,2′′′-Quaterthiophene 96%
|
|
B012
|
6-Fluoronorepinephrine hydrochloride solid
|
|
74530
|
L-(−)-Norephedrine purum, ≥98.0% (NT)
|
|
B9308
|
BP897 >98% (HPLC), solid
|
|
C6305
|
Clozapine
|
|
D9815
|
Doxazosin mesylate ≥97% (HPLC), powder
|
|
E2031
|
Eliprodil ≥98% (HPLC), solid
|
|
H1512
|
Haloperidol powder
|
|
L3040
|
L-765,314 hydrate ≥98% (HPLC), solid
|
|
M0443
|
Mirtazapine ≥98% (HPLC), solid
|
|
C7230
|
N-[2-(4-(4-Chlorophenyl)piperazin-1-yl)ethyl]-3-methoxybenzamide solid
|
|
R103
|
Ritanserin solid
|
|
S0693
|
SB 204741 >98% (HPLC)
|
|
S0568
|
SB-200646 hydrochloride >98% (HPLC), solid
|
|
S7395
|
Spiperone solid
|
|
594687
|
α-Sexithiophene
|
